Frankel AE - Search Results

1

GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials.

Woo JH, Liu JS, Kang SH, Singh R, Park SK, Su Y, Ortiz J, Neville DM Jr, Willingham MC, Frankel AE. Woo JH, et al. Among authors: frankel ae. Protein Expr Purif. 2008 Mar;58(1):1-11. doi: 10.1016/j.pep.2007.11.006. Epub 2007 Nov 22. Protein Expr Purif. 2008. PMID: 18160309

2

Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.

Urieto JO, Liu T, Black JH, Cohen KA, Hall PD, Willingham MC, Pennell LK, Hogge DE, Kreitman RJ, Frankel AE. Urieto JO, et al. Among authors: frankel ae. Protein Expr Purif. 2004 Jan;33(1):123-33. doi: 10.1016/j.pep.2003.09.003. Protein Expr Purif. 2004. PMID: 14680969

3

Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1).

Woo JH, Bour SH, Dang T, Lee YJ, Park SK, Andreas E, Kang SH, Liu JS, Neville DM Jr, Frankel AE. Woo JH, et al. Among authors: frankel ae. Cancer Immunol Immunother. 2008 Aug;57(8):1225-39. doi: 10.1007/s00262-008-0457-x. Epub 2008 Feb 7. Cancer Immunol Immunother. 2008. PMID: 18256829 Free PMC article.

4

Characterization of variant diphtheria toxin-interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials.

Su Y, Li SY, Ghosh S, Ortiz J, Hogge DE, Frankel AE. Su Y, et al. Among authors: frankel ae. Biologicals. 2010 Jan;38(1):144-9. doi: 10.1016/j.biologicals.2009.08.016. Epub 2009 Sep 23. Biologicals. 2010. PMID: 19783458

5

Pharmacology of anti-CD3 diphtheria immunotoxin in CD3 positive T-cell lymphoma trials.

Woo JH, Lee YJ, Neville DM, Frankel AE. Woo JH, et al. Among authors: frankel ae. Methods Mol Biol. 2010;651:157-75. doi: 10.1007/978-1-60761-786-0_10. Methods Mol Biol. 2010. PMID: 20686966

6

Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma.

Frankel AE, Zuckero SL, Mankin AA, Grable M, Mitchell K, Lee YJ, Neville DM, Woo JH. Frankel AE, et al. Curr Drug Targets. 2009 Feb;10(2):104-9. doi: 10.2174/138945009787354539. Curr Drug Targets. 2009. PMID: 19199905 Review.

7

Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia.

Frankel A, Liu JS, Rizzieri D, Hogge D. Frankel A, et al. Leuk Lymphoma. 2008 Mar;49(3):543-53. doi: 10.1080/10428190701799035. Leuk Lymphoma. 2008. PMID: 18297533 Clinical Trial.

8

Systematic urokinase-activated anthrax toxin therapy produces regressions of subcutaneous human non-small cell lung tumor in athymic nude mice.

Su Y, Ortiz J, Liu S, Bugge TH, Singh R, Leppla SH, Frankel AE. Su Y, et al. Among authors: frankel ae. Cancer Res. 2007 Apr 1;67(7):3329-36. doi: 10.1158/0008-5472.CAN-06-4642. Cancer Res. 2007. PMID: 17409442

9

Antibody internalization after cell surface antigen binding is critical for immunotoxin development.

Kuo SR, Alfano RW, Frankel AE, Liu JS. Kuo SR, et al. Among authors: frankel ae. Bioconjug Chem. 2009 Oct 21;20(10):1975-82. doi: 10.1021/bc900333j. Epub 2009 Sep 28. Bioconjug Chem. 2009. PMID: 19785403

10

Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma.

Frankel AE, Woo JH, Ahn C, Foss FM, Duvic M, Neville PH, Neville DM. Frankel AE, et al. Haematologica. 2015 Jun;100(6):794-800. doi: 10.3324/haematol.2015.123711. Epub 2015 Mar 20. Haematologica. 2015. PMID: 25795722 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters